Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

The Compatibility of Common Respiratory Therapy Drug Combinations

Author(s):  Owsley Heather D, Rusho William F

Issue:  Mar/Apr 1997 - Pediatric Care
View All Articles in Issue

Page(s):  121-122

The Compatibility of Common Respiratory Therapy Drug Combinations Page 1
The Compatibility of Common Respiratory Therapy Drug Combinations Page 2

Download in electronic PDF format for $75

Abstract:  Respiratory therapists are being asked to take care of sicker patients and in many cases this requires the administration of multiple inhalation drugs. In an effort to reduce the workload, therapists are combining drugs in the same nebulizer. Pharmacists also are being asked to prepare unit dose preparations of combined inhalation drugs without physical compatibility data. It is theorized that some drug combinations precipitate and that these particulates are ultimately inhaled into the patient’s lungs. These particulates can cause locally high concentrations of drug resulting in tissue irritation or actual occlusion of the airway. This study tested the physical compatibility of 22 common combinations used in our hospital and found 19 of these combinations incompatible. Due to the potential of precipitation,we recommend that inhalation drugs not be routinely combined without specific compatibility data.

Related Keywords: Respiratory therapy, drug combinations, incompatibility of, Respiratory therapy, precipitation of drugs in

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
The Compatibility of Common Respiratory Therapy Drug Combinations
Owsley Heather D
, Rusho William F
Mar/Apr 1997
Pg. 121-122

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna
, Jones William, Stephenson Douglas M M
May/Jun 2006
Pg. 175-183

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Technology Spotlight: Respiratory Vial Sealers
Allen Loyd V Jr
Sep/Oct 2003
Pg. 364-365

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
May/Jun 2007
Pg. 200

Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
Sep/Oct 2007
Pg. 416

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
Jan/Feb 2007
Pg. 56-58

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
Nov/Dec 2012
Pg. 456-460

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Return to Top